proCardio Asia Pacific

Related Links

• MASH and Hepatic Fibrosis: Intersecting Metabolic Pathways
• How to Manage PMI? - Practical Implementation in Ramathibodi Hospital
• Lp(a) Screening at Least Once a Lifetime! Unwrapping the What, Why and How's of Lipoprotein(a)
• NT-proBNP as a predictor of Cardio-renal Complications in PwD
• Safety of Rx Optimisation Post AHF Hospitalization
• Practical Implementation of GDMT Optimisation - The ATP in NZ
• Use of Rapid Algo for Suspected AMI - Faster Triage of ED Patients
• Navigating Cardiotoxicity - Value of Cardiac Biomarkers
• DROP Asian ACS - Study Results and Practical Approach
• The Importance of Early Diagnosis and Management of AHF
• Integrative Approaches to Managing Diabetes and Cardiovascular Disease
• Optimising GDMT Post AHF Discharge - APAC APSC Consensus Highlights
• Initiation of GDMT Therapy in Patients Discharged Post AHF - What are the Guardrails?
• Enhancing Diabetes and Cardiovascular Management with Continuous Glucose Monitoring
• New Frontiers for Risk Stratification Assays for Acute Coronary Syndrome - The Gen6 Assay for hs cTnT
• NT-proBNP for Rapid Optimisation of GDMT in AHF Patients in Japan
• STRONG-HF: Implementation of GDMT Heart Failure Therapy & Post-discharge Heart Failure Management
• NT-proBNP and ECHO in heart failure - do they always go hand in hand?
• Rapid ACS Rule Out in Emergency Patients
• How to Implement the 0-h/1-h Algorithm to your Institute?
• High Sensitivity Cardiac Troponins and ACS - the Malaysian Experience
• APAC Heart Failure Gap Report
• Value of NT-ProBNP for Treatment Monitoring in CHF